EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 3.0

Plasma–Enhanced Chemical Vapor Deposition of Biocompatible Coatings for Controlled Drug Release Systems: A Systematic Review

Seema Sharma, Uttam Sharma, Sampat Singh Tanwar

Premier Journal of Science · 27.02.2026

DOI: 10.70389/pjs.100264 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Premier Journal of Science, online erschienen am 27.02.2026. Verfasst von Seema Sharma und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasma-enhanced chemical vapor deposition (PECVD) has emerged as a powerful technique for engineering biocompatible, conformal coatings that enable precise control of drug release from medical devices and delivery platforms. This systematic review synthesizes experimental evidence on PECVD-derived coatings used for controlled drug delivery, with a focus on structure property function relationships, biocompatibility, and translational readiness. Across applications such as drug-eluting stents, orthopedic implants, wound dressings, ophthalmic devices, and particulate carriers, PECVD enabled nanometer-to micrometer-scale control of film thickness, crosslinking density, surface energy, and functional group content, which in turn allowed modulation of burst release, release duration, and responsiveness to pH, enzymes, or redox environment. Many coatings demonstrated favourable cytocompatibility and hemocompatibility, with several studies also incorporating antimicrobial or cell-adhesive functionalities into the same layer. However, most investigations were limited to short-term in vitro assays or small animal models, and process descriptions were often insufficient to ensure reproducibility or scale-up. Long-term stability, chronic tissue response, and comprehensive regulatory-grade characterization remain incompletely addressed. Overall, PECVD offers a flexible, substrate-agnostic route to multifunctional biocompatible coatings for controlled drug release, but translation will require standardized reporting of plasma parameters, systematic in vivo safety and durability testing, and integration of PECVD within quality-by-design and Good Manufacturing Practice frameworks.

Zitieren

APA

Sharma, S., Sharma, U., & Tanwar, S. S. (2026). Plasma–Enhanced Chemical Vapor Deposition of Biocompatible Coatings for Controlled Drug Release Systems: A Systematic Review. Premier Journal of Science. https://doi.org/10.70389/pjs.100264

Vancouver

Sharma S, Sharma U, Tanwar SS. Plasma–Enhanced Chemical Vapor Deposition of Biocompatible Coatings for Controlled Drug Release Systems: A Systematic Review. Premier Journal of Science. 2026. doi:10.70389/pjs.100264

BibTeX
@article{Sharma2026,
  author = {Sharma, Seema and Sharma, Uttam and Tanwar, Sampat Singh},
  title = {Plasma–Enhanced Chemical Vapor Deposition of Biocompatible Coatings for Controlled Drug Release Systems: A Systematic Review},
  journal = {Premier Journal of Science},
  year = {2026},
  doi = {10.70389/pjs.100264}
}
Kostenlos starten →